| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/1995 | US5386041 Antibiotic |
| 01/31/1995 | US5386034 2-(alkoxy benzothiazolinon-3yl) ethylamines |
| 01/31/1995 | US5386031 Process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4H-pyrrolo[3,]pyrimidin-4-ones |
| 01/31/1995 | US5386030 Chemical intermediates |
| 01/31/1995 | US5386028 Nuclear magnetic imaging contrast agent; medical diagnosis |
| 01/31/1995 | US5386027 Carbohydrate receptor for bacteria and method for use thereof |
| 01/31/1995 | US5386016 Acylation of an aglcone in presence of a Lewis acid |
| 01/31/1995 | US5385947 Octahydrophenanthrene derivatives |
| 01/31/1995 | US5385946 Administering hypotensive agents |
| 01/31/1995 | US5385945 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds |
| 01/31/1995 | US5385944 Treating or preventing disorders of melatoninergic system |
| 01/31/1995 | US5385943 Use of topically applicable preparations for treatment of presbyderma |
| 01/31/1995 | US5385942 Quinone derivatives and pharmacological use |
| 01/31/1995 | US5385941 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
| 01/31/1995 | US5385940 Treatment of stroke with nitric-oxide releasing compounds |
| 01/31/1995 | US5385939 Preventing the axial elongation myopia in the eye by administering a gama-aminobutyric acid receptor antagonist |
| 01/31/1995 | US5385938 application of mixtures containing hydroxyacetic acid(or its salts) to skin |
| 01/31/1995 | US5385937 Preventing peroxide generation from mercaptan groups and endothelial injury |
| 01/31/1995 | US5385936 Gossypol acetic acid for the treatment of cancer |
| 01/31/1995 | US5385935 Method for the inhibition of restenosis associated with coronary intervention |
| 01/31/1995 | US5385933 Method for the treatment of cancer by use of the copper complex of S-(methylthio)-DL-homocysteine or the L-enantiomorph thereof |
| 01/31/1995 | US5385932 Anticholesterol, antilipemic agents |
| 01/31/1995 | US5385931 Multistage formation of sulfonamides by reaction of esters and acyl halides, nitriding, reduction and sulfonylation to form cardiovascular compounds |
| 01/31/1995 | US5385930 Treating central nervous system disorders like anxiety and depression |
| 01/31/1995 | US5385929 [(Hydroxyphenylamino) carbonyl] pyrroles |
| 01/31/1995 | US5385928 Antiserotonine agent |
| 01/31/1995 | US5385927 Hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]-benzenecarboximidamides and their use in treating glaucoma |
| 01/31/1995 | US5385923 Treatment of degenerative diseases |
| 01/31/1995 | US5385922 Thiazolidine derivatives |
| 01/31/1995 | US5385921 Treatment for neurodegeneration, alzheimer's disease, huntington's chorea; antihypoxic agents, antiischemic agents |
| 01/31/1995 | US5385920 Diacylglycerol nicotinates |
| 01/31/1995 | US5385919 Antidiabetic agents |
| 01/31/1995 | US5385918 Aminomethylene-peptides as immunosuppressants |
| 01/31/1995 | US5385917 Carboxylic acid derivatives |
| 01/31/1995 | US5385916 Neuroleptic agents |
| 01/31/1995 | US5385915 Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation |
| 01/31/1995 | US5385914 Cardiotonic carbostyril agents for treating heart ailments |
| 01/31/1995 | US5385912 Multicyclic tertiary amine polyaromatic squalene synthase inhibitors |
| 01/31/1995 | US5385911 Potent inhibitors of glycoprotein processing enzymes |
| 01/31/1995 | US5385909 Heterocyclic esters of rapamycin |
| 01/31/1995 | US5385908 Immunosuppressants, antiinflammatory agents |
| 01/31/1995 | US5385907 Ointments containing FK-506 or derivatives thereof |
| 01/31/1995 | US5385904 Therapy for immunology diseases |
| 01/31/1995 | US5385903 Pharmaceutical agent for treatment of withdrawal symptoms |
| 01/31/1995 | US5385901 Method of treating abnormal concentrations of TNF α |
| 01/31/1995 | US5385900 A 1H-1,4-diazepin-5-one-oxoquinoline carboxylic acids microbiocides especial against grampositive bacterial |
| 01/31/1995 | US5385899 Aminoalkyl-substituted 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes |
| 01/31/1995 | US5385898 Hypertensive agents; cardiovascular disorders; renin inhibitors; glaucoma |
| 01/31/1995 | US5385891 Polysulfate of β-cyclodextrin derivative and process for preparing the same |
| 01/31/1995 | US5385832 Cultivating cells in growth medium, separating, extracting with methanol and chloroform, acid-washing |
| 01/31/1995 | US5385739 Stable compositions of gastroprotected omerprazole microgranules and process for the production thereof |
| 01/31/1995 | US5385738 Sustained-release injection |
| 01/31/1995 | US5385736 Sheet with coating of melatonin, carbitol and pressure sensitive adhesive containing terpolymers of acrylic esters, (substituted)acrylamides or N-vinylpyrrolidone/2-/, with vinyl acetate |
| 01/31/1995 | US5385735 Semduramicin premix |
| 01/31/1995 | US5385734 Horseradish preparation for the treatment of nasal and sinus dysfunction |
| 01/31/1995 | US5385733 Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus |
| 01/31/1995 | US5385726 Reducting side effects of cisplatin |
| 01/31/1995 | CA2129215A1 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| 01/31/1995 | CA2129214A1 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives |
| 01/31/1995 | CA2128751A1 Use of benzenesulphonylindole derivatives for the preparation of medicines |
| 01/31/1995 | CA2128671A1 1-aryloxy-3-alkylamino-2-propanol nitrate esters, the use thereof and corresponding pharmaceutical composition |
| 01/31/1995 | CA1334207C Process for preparing high-concentration mixtures of elcosapentaenoic acid and docosahexaenoic acid and of their esters from oils of animal and/or vegetable origin |
| 01/31/1995 | CA1334201C Cardiotonic alkanoyl and aroyl oxazolones |
| 01/31/1995 | CA1334200C Leukotriene antagonists |
| 01/31/1995 | CA1334199C Dopamine beta hydroxylase inhibitors |
| 01/31/1995 | CA1334197C Hetera-aliphatic carboxamides |
| 01/31/1995 | CA1334196C Arylmethylazoles and their salts, processes for their preparation, agents which contain these compounds, and their use |
| 01/31/1995 | CA1334173C Composition for desorbing bacteria |
| 01/31/1995 | CA1334170C Methods of treating tumors with compositions of catecholic butanes |
| 01/31/1995 | CA1334169C Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
| 01/31/1995 | CA1334168C Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers |
| 01/31/1995 | CA1334167C Method of preventing or reducing platelet loss during extra-corporeal circulation using a thromboxane a receptor antagonist |
| 01/31/1995 | CA1334166C Antiviral preparation containing dideoxy-nucleosides |
| 01/30/1995 | CA2126523A1 Jak kinases and regulation of cytokine signal transduction |
| 01/29/1995 | CA2128954A1 Spermicidal anti-viral lubricant composition and method of using same |
| 01/27/1995 | CA2128547A1 Method for the separation of bacterial lipopolysaccharides from protein-containing solutions |
| 01/27/1995 | CA2127384A1 Substituted azepino ¬2,1-a| isoquinoline compounds |
| 01/26/1995 | WO1995002697A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | WO1995002613A2 Heparin derivatives having antimetastatic activity |
| 01/26/1995 | WO1995002603A2 Use of cephem derivatives as anti-metastatic agents |
| 01/26/1995 | WO1995002602A1 Imidazo(1,2-a)pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists |
| 01/26/1995 | WO1995002601A1 IMIDAZO[1,2-a]PYRAZINE-4-ONE, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/26/1995 | WO1995002600A1 Antiallergic imidazoazepines |
| 01/26/1995 | WO1995002598A1 Fused cycloalkylimidazopyridines |
| 01/26/1995 | WO1995002597A1 IMIDAZO[4,5-c]PYRIDIN-4-AMINES |
| 01/26/1995 | WO1995002596A1 Azacyclic-heterocyclic compounds as angiotensin ii receptor antagonists |
| 01/26/1995 | WO1995002595A1 Benzyloxyquinuclidines as substance p antagonists |
| 01/26/1995 | WO1995002594A1 Amide derivatives of 16-membered ring antibiotic macrolides |
| 01/26/1995 | WO1995002593A1 Piperazine derivatives and salts thereof |
| 01/26/1995 | WO1995002592A1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists |
| 01/26/1995 | WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | WO1995002588A1 Use of coumarins and carbostyrils as pla2-inhibitors, new coumarins and carbostyrils, process for preparing the same and medicaments |
| 01/26/1995 | WO1995002587A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists |
| 01/26/1995 | WO1995002585A1 Enanthioselective preparation of thiazole derivatives |
| 01/26/1995 | WO1995002583A1 Process for making hiv protease inhibitors |
| 01/26/1995 | WO1995002582A1 Cyclic hydrazine compounds |
| 01/26/1995 | WO1995002577A1 Novel vitamin d analogues |
| 01/26/1995 | WO1995002572A1 Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent |
| 01/26/1995 | WO1995002566A1 Synthesis of combinatorial arrays of organic compounds through the use of multiple component combinatorial array syntheses |
| 01/26/1995 | WO1995002420A2 Prodrugs of protein tyrosine kinase inhibitors |